Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Non-cash Items (2016 - 2020)

Historic Non-cash Items for Myriad Genetics (MYGN) over the last 11 years, with Q2 2020 value amounting to $4.8 million.

  • Myriad Genetics' Non-cash Items fell 1272.73% to $4.8 million in Q2 2020 from the same period last year, while for Jun 2020 it was $4.8 million, marking a year-over-year decrease of 1272.73%. This contributed to the annual value of $4.8 million for FY2020, which is 1272.73% down from last year.
  • Latest data reveals that Myriad Genetics reported Non-cash Items of $4.8 million as of Q2 2020, which was down 1272.73% from $5.0 million recorded in Q3 2019.
  • In the past 5 years, Myriad Genetics' Non-cash Items ranged from a high of $8.6 million in Q1 2016 and a low of $4.8 million during Q2 2020
  • Moreover, its 5-year median value for Non-cash Items was $7.1 million (2016), whereas its average is $6.7 million.
  • As far as peak fluctuations go, Myriad Genetics' Non-cash Items tumbled by 6475.41% in 2016, and later soared by 1194.03% in 2017.
  • Over the past 5 years, Myriad Genetics' Non-cash Items (Quarter) stood at $7.6 million in 2016, then fell by 1.32% to $7.5 million in 2017, then dropped by 16.0% to $6.3 million in 2018, then fell by 20.63% to $5.0 million in 2019, then dropped by 4.0% to $4.8 million in 2020.
  • Its last three reported values are $4.8 million in Q2 2020, $5.0 million for Q3 2019, and $5.5 million during Q2 2019.